Rigel Pharmaceuticals RIGL
NASDAQ RIGL
$48.79 +0.68 (+1.41%)
As of: Oct 21, 2026 · 3:32 PM EDT

Rigel Pharmaceuticals (RIGL) Total Non-Current Liabilities (2010 - 2025)

Updated

Rigel Pharmaceuticals' Total Non-Current Liabilities was $122.11 million in Q4 2025, up 1.2% from $120.71 million a year earlier and up 1.8% from the prior quarter.

Analysis

Rigel Pharmaceuticals (RIGL) Total Non-Current Liabilities (2010 - 2025) Analysis & Trends

From Q4 2010 onward, Rigel Pharmaceuticals has reported Total Non-Current Liabilities for 54 quarters.

  • Total Non-Current Liabilities has now increased for five consecutive years, with a five-year compound annual growth rate of 11.4% (FY2020 to FY2025).
  • In earlier years, Total Non-Current Liabilities was $120.71 million in FY2024 (+14.0%), $105.93 million in FY2023 (+0.3%), $105.63 million in FY2022 (+25.4%) and $84.23 million in FY2021 (+18.1%).
  • The Q4 2025 figure marks the highest quarterly Total Non-Current Liabilities since Q3 2024.
  • Compared with a year earlier, Total Non-Current Liabilities was higher in five of the last eight quarters, with growth averaging 8.9%.
  • The best year-over-year quarter for Total Non-Current Liabilities over five years was Q2 2024 (growth of 37.5%); the worst was Q3 2025 (a decline of 19.5%).
  • Per Business Quant data, RIGL's Total Non-Current Liabilities in the three quarters before Q4 2025 was $119.93 million (Q3 2025), $119.8 million (Q2 2025) and $117.42 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,137.26 Bn 1,105.84 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 618.12 Bn 536.65 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.25 Bn 476.36 Bn 12.70 Bn 106.45 Bn
4 Merck 368.28 Bn 322.66 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.45 Bn 262.44 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.39 Bn 235.08 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.30 Bn 192.70 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.35 Bn 165.55 Bn 6.22 Bn 35.10 Bn
9 Pfizer 169.92 Bn 116.56 Bn 10.94 Bn 97.04 Bn
10 Rigel Pharmaceuticals 905.73 Mn 371.62 Mn 70.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 122.11 Mn
Sep 30, 2025 119.93 Mn
Jun 30, 2025 119.80 Mn
Mar 31, 2025 107.42 Mn
Dec 31, 2024 115.71 Mn
Sep 30, 2024 149.06 Mn
Jun 30, 2024 143.32 Mn
Mar 31, 2024 142.97 Mn
Dec 31, 2023 105.93 Mn
Sep 30, 2023 108.40 Mn
Jun 30, 2023 104.23 Mn
Mar 31, 2023 105.80 Mn
Dec 31, 2022 105.63 Mn
Sep 30, 2022 86.73 Mn
Jun 30, 2022 84.79 Mn
Mar 31, 2022 89.07 Mn
Dec 31, 2021 84.23 Mn
Sep 30, 2021 82.48 Mn
Jun 30, 2021 85.26 Mn
Mar 31, 2021 80.16 Mn
API Access

Rigel Pharmaceuticals Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RIGL&period=max&api_key=YOUR_API_KEY